COMMUNIQUÉS West-GlobeNewswire

DLH Reports Fiscal 2026 Third Quarter Results
29/07/2026
ATLANTA, July 29, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cybersecurity, systems engineering and integration, and science [...]
MIMEDX to Acquire Sanara MedTech
29/07/2026
Transformational Combination Creates a Leading Regenerative Medicine Company Across Numerous Surgical Subspecialties Accelerates MIMEDX’s Strategic Priority to Expand Surgical Footprint, Nearly Doubling Surgical Revenue [...]
OrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth Conference
29/07/2026
WARSAW, Ind., July 29, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
Teladoc Health Reports Second Quarter 2026 Results
29/07/2026
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2026 (“Second Quarter 2026”). Unless [...]
Onco360® Has Been Selected as a National Pharmacy Partner for VEPPANU™ (vepdegestrant)
29/07/2026
LOUISVILLE, Ky., July 29, 2026 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Rigel Pharmaceuticals for VEPPANU™ (vepdegestrant), which is [...]
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
29/07/2026
Data indicate that the 2026-2027 COVID-19 vaccine formula, targeting the XFG variant, induces a strong immune response against contemporary circulating and emerging lineages More than five billion doses of the Pfizer- [...]
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
29/07/2026
MALVERN, Pa., July 29, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
29/07/2026
- Biologics License Application (BLA) for z-rostudirsen in exon 51 DMD accepted for review by FDA; Priority Review granted; PDUFA target action date set for January 21, 2027 - - Completed enrollment of 71 participants [...]
VitalHub Announces Q2 2026 Conference Call Date
29/07/2026
TORONTO, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced today that it will release financial results for the second quarter 2026 ended June 30, [...]
Inventiva annonce ses résultats financiers préliminaires pour le premier semestre 2026¹
29/07/2026
Trésorerie et équivalents de trésorerie de 166,1 millions d'euros et 67,8 millions d'euros de dépôts à court terme 2 au 30 juin 2026 Daix (France), New York City (New York, États-Unis), le 29 juillet, 2026 – Inventiva ( [...]
BioStem Technologies to Host Second Quarter 2026 Financial Results Conference Call on August 12, 2026
29/07/2026
Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company [...]
First-half 2026 results
29/07/2026
Half-Year Results: strong improvement in operating performance Successful refinancing transactions Objectives confirmed Strong improvement in operating performance Revenue as at 30 June 2026 stood at €2,699m, up +4.6% [...]
EssilorLuxottica: Publication of the 2026 Interim Financial Report
29/07/2026
Publication of the 2026 Interim Financial Report Paris, France (29 July 2026 – 6:00 pm) – The Board of Directors of EssilorLuxottica met on July 28, 2026 to approve the condensed consolidated interim financial [...]
New Research using Clue Data Suggests Menstrual Cycle Timing May Influence Vaccine Side Effects
29/07/2026
A new study using Clue's menstrual tracking data finds women vaccinated during the follicular phase were more likely to self-report side effects and had a longer time to subsequent infection than those vaccinated during [...]
Résultats semestriels 2026
29/07/2026
Résultats au 30 juin 2026 : forte progression de la performance opérationnelle Succès des opérations de refinancement Objectifs confirmés Forte progression de la performance opérationnelle Le chiffre d’affaires au 30 [...]
EssilorLuxottica: Mise à disposition du Rapport financier semestriel 2026
29/07/2026
Mise à disposition du Rapport financier semestriel 2026 Paris, France (29 juillet 2026 – 18h00) – Le Conseil d’administration d’EssilorLuxottica, qui s’est réuni le 28 juillet 2026, a arrêté les comptes consolidés [...]
First-Half 2026 results confirm commercial and operational resilience in a challenging market environment - Transformation progressing as planned, including the divestment of the Brindisi site
29/07/2026
Press Release Paris, 29th July 2026 €356.5 million Net Sales, down 13.5% year-on-year as reported and -11.8% on a comparative basis 1 As expected, including a negative €13 million impact from the planned discontinuation [...]
Les résultats du premier semestre 2026 confirment la résilience commerciale et opérationnelle dans un environnement de marché difficile - La transformation progresse selon le calendrier avec notamment la cession du site de Brindisi
29/07/2026
Communiqué de presse Paris, le 29 juillet 2026 Chiffre d’affaires de 356,5 millions d’euros, en baisse de 13,5% par rapport au S1 2025 et de -11,8% sur une base comparable 1 Comme prévu, incluant un impact négatif de 13 [...]
F6S Ranks Life Backup Plan 55th in Health and Wellness
29/07/2026
National ranking accompanies recognition from Pepperdine, TiE, ASCEND LA and two healthcare publications Aliso Viejo, CA, July 29, 2026 (GLOBE NEWSWIRE) -- F6S ranks Life Backup Plan® 55th on its, “ 100 Top Health [...]

Pages